Código QR (código de barras bidimensional)

Design of an Array to Evaluate Biomarkers of Response to Biological Treatments in Inflammatory Bowel Disease

Background: Inflammatory bowel disease (IBD) is defined as recurrent inflammatory bowel disorders, the most common of which are Crohn’s disease (CD) and ulcerative colitis (UC). Tumor necrosis factor inhibitors (anti-TNFs), primarily adalimumab (ADA), infliximab (IFX), ustekinumab (UST), and vedoliz...

ver descrição completa

Na minha lista:
Principais autores: Andrea Rodríguez-Lopez, Eva González-Iglesias, Jesús Novalbos, Susana Almenara, Francisco Abad-Santos
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2025-07-01
coleção:Future Pharmacology
Assuntos:
inflammatory bowel disease
Crohn’s disease
ulcerative colitis
adalimumab
infliximab
SNV
Acesso em linha:https://www.mdpi.com/2673-9879/5/3/39
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados